CIA
RMD icon

Capital Impact Advisors’s ResMed RMD Stock Holding History

Capital Impact Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.5M Buy
151,525
+113,479
+298% +$23.5M 1.66% 26
2026
Q1 		$8.54M Sell
38,046
-121,312
-76% -$30.2M 3.45% 9
2025
Q4 		$38.4M Buy
159,358
+114,318
+254% +$29.2M 3% 15
2025
Q3 		$12.3M Buy
45,040
+8,173
+22% +$2.23M 2.76% 17
2025
Q2 		$9.61M Sell
36,867
-1,272
-3% -$303K 2.89% 14
2025
Q1 		$8.54M Buy
+38,139
New +$8.9M 3.27% 13
2023
Q1 		– Sell
-1,916
Closed -$399K – 223
2022
Q4 		$399K Buy
1,916
+56
+3% +$12.3K 0.39% 110
2022
Q3 		$406K Sell
1,860
-536
-22% -$122K 0.4% 102
2022
Q2 		$502K Sell
2,396
-1,096
-31% -$233K 0.46% 94
2022
Q1 		$847K Sell
3,492
-1,956
-36% -$473K 0.62% 62
2021
Q4 		$1.42M Hold
5,448
– – 0.98% 38
2021
Q3 		$1.44M Buy
+5,448
New +$1.49M 0.57% 76
2021
Q1 		– Sell
-16,125
Closed -$3.43M – 130
2020
Q4 		$3.43M Hold
16,125
– – 0.84% 50
2020
Q3 		$2.76M Hold
16,125
– – 0.82% 54
2020
Q2 		$3.1M Hold
16,125
– – 1.03% 27
2020
Q1 		$2.38M Buy
+16,125
New +$2.57M 1% 31
2016
Q2 		– Sell
-22,484
Closed -$1.3M – 233
2016
Q1 		$1.3M Buy
22,484
+984
+5% +$55.7K 0.62% 31
2015
Q4 		$1.15M Buy
+21,500
New +$1.21M 0.55% 44

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital Impact Advisors's RMD Position: Q2 2026 in Review

Capital Impact Advisors increased its ResMed (RMD) stake by 298% in Q2 2026, buying an estimated $23.5M and bringing the position to 151,525 shares worth $29.5M. The position accounts for 1.66% of the portfolio, ranked #26.

Capital Impact Advisors first reported a position in RMD in Q4 2015 and has held it in 18 quarters since. The position peaked at $38.4M in Q4 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Capital Impact Advisors held 151,525 shares of ResMed worth $29.5M as of Q2 2026.
  • Capital Impact Advisors bought 113,479 ResMed shares in Q2 2026, an estimated $23.5M.
  • ResMed made up 1.66% of Capital Impact Advisors's portfolio in Q2 2026, its #26 holding.
  • Capital Impact Advisors first reported a position in ResMed in Q4 2015 and has held it in 18 quarters since.
  • Capital Impact Advisors's ResMed position peaked at $38.4M in Q4 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Capital Impact Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.